Population
Patients with end stage lung diseases undergoing lung or heart-lung transplantation
Design
Review
Authors
Loading...
BOS carries high mortality without proven therapies in lung transplant recipients; leaves open critical gaps in pathogenesis and prevention.
Bronchiolitis obliterans syndrome is a fatal complication of lung and heart-lung transplantation with no proven therapies, necessitating further research into its complex pathogenesis.
Belperio et al. (2003) studied this question.